In this episode, Dr. Alan Sacerdote MD, an endocrinologist specializing in diabetes and metabolism, discusses the crucial role of Vitamin D in metabolic health. Discover how Vitamin D deficiency correlates with various metabolic conditions and learn practical strategies for supplementation and lifestyle adjustments. Tune in for expert insights into optimizing metabolic health with Vitamin D.

Dr. Sacerdote occupied the position of Chief of the Endocrinology Division at NYC Health and Hospitals Woodhull, and served as a Professor at SUNY Downstate Medical Center and New York University School of Medicine, among others.

This conversation was based on the following article:
Reference: Sacerdote A, Dave P, Lokshin V, Bahtiyar G. Type 2 Diabetes Mellitus, Insulin Resistance, and Vitamin D. Curr Diab Rep. 2019 Sep 10;19(10):101. doi: 10.1007/s11892-019-1201-y. PMID: 31506836.

Follow me on social media:
Instagram:   / doctoref.rain  
Facebook:   / efrain.riverosperez  

Chapters:
00:00 Coming up
04:25 Episode start
05:50 Introduction to the episode
06:25 Motivation to start researching insulin resistance and diabetes
08:51 The association between metabolic disorders and Vitamin D
14:09 Considerations when conducting research and trials on the topic
23:30 Normal Vitamin D plasma levels
25:30 Expectations when supplementing vitamin D
33:48 Other research considerations
35:15 Opinion on Mendelian randomization
36:56 Vitamin D and mortality
42:33 Advice for researchers
50:55 About other insulin sensitizers
52:43 Final words

Disclosure:
The content of this podcast is purely academic in nature and is intended for educational and informational purposes only. The material discussed does not represent or reflect the views, opinions, or policies of the Medical College of Georgia, and the information presented should not be construed as medical advice or guidance. Always consult with a qualified healthcare professional for any medical concerns or questions. I'd like to explicitly state that I have no endorsement from, affiliations with, or financial interests in any pharmaceutical companies or medical device manufacturers. Any mention of medications, devices, or treatments is made solely within the context of literature and academic discussion.